title: Chemotherapy and herceptin for HER2(+) metastatic breast cancer: the best drug?
authors.affiliation: Department of Medicine, Seatle Cancer Care Alliance, Seattle, Washington 98109, USA.
authors.forename: R B
authors.initials: RB
authors.lastname: Livingston
authors.forename: F J
authors.initials: FJ
authors.lastname: Esteva
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000378:metabolism / Q000628:therapy*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism*; D000068878:Trastuzumab
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D018719:Erb-b2 Receptor Tyrosine Kinases; D000068878:Trastuzumab